# VEMLIDY

NDC: 61958-2301
Generic name: tenofovir alafenamide
Labeler / Manufacturer: Gilead Sciences, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20161110

FDA application: NDA208464

## Active ingredients

- TENOFOVIR ALAFENAMIDE FUMARATE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61958-2301"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61958-2301
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72e6b33c-0351-4070-9172-eeaa186c01d2